Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer

A number of immunotherapies have been developed and adopted for the treatment of urothelial cancer (encompassing cancers arising from the bladder, urethra, or renal pelvis). For these immunotherapies to positively impact patient outcomes, optimal selection of agents and treatment scheduling, especia...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Immunother Cancer
Hlavní autoři: Galsky, Matthew D, Balar, Arjun V, Black, Peter C, Campbell, Matthew T, Dykstra, Gail S, Grivas, Petros, Gupta, Shilpa, Hoimes, Christoper J, Lopez, Lidia P, Meeks, Joshua J, Plimack, Elizabeth R, Rosenberg, Jonathan E, Shore, Neal, Steinberg, Gary D, Kamat, Ashish M
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2021
Témata:
Position Article and Guidelines
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8286774/
https://ncbi.nlm.nih.gov/pubmed/34266883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2021-002552
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky